Fierce Healthcare

MAY 8, 2024

Ascension disclosed Wednesday that it has detected “unusual activity” on some of its technology networks that it believes “is due to a cybersecurity event.” | The Catholic health giant said it detected "unusual activity" Wednesday and "immediately" activated remediation processes, including hiring a third-party cybersecurity firm. (..)

142

142

pharmaphorum

OCTOBER 11, 2024

Today, it proudly holds the mantle as Europe’s flagship partnering event. In 1994, BIO-Europe launched with the mission to drive biotech innovation and dealmaking forward through one-to-one partnering.

52

52

STAT

OCTOBER 2, 2024

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter: Rarely before has a large-cap biotech had so much riding on the outcome of a Phase 2 study as Amgen does with its obesity treatment MariTide , also known as AMG 133. Results are coming before the end of the year.

107

107

STAT

SEPTEMBER 17, 2024

Called “AI in Action: Transforming Health and Human Services,” the three-hour event is hosted by the federal health department. Federal health officials wrestling with when and how to use artificial intelligence will on Wednesday host an invitation-only meeting of AI leaders across industry, academia, and government.

Medical Schools 123

Medical Schools FDA Hospitals 123

Pharmacy Times

JULY 17, 2024

Currently, limited data show the effect of adverse drug events in the outpatient setting.

132

132

Fierce Healthcare

DECEMBER 27, 2023

A hospital’s acquisition by a private equity firm is linked to a rise in adverse events despite the pool of lower risk patients they tend to admit, according to a Medicare Part A claims analysis pu | Hospital-acquired adverse events among Medicare beneficiaries were 25% higher within the three years after a private equity acquisition compared to control (..)

Hospitals 136

Hospitals 136

Pharmacy Times

SEPTEMBER 16, 2024

The discussion covers proactive strategies and interventions for managing adverse events before dose modification and explores supportive care measures for chronic lymphocytic leukemia treatments, including variations based on specific Bruton tyrosine kinase inhibitors.

65

65

STAT

JUNE 5, 2024

Editor’s note: A livestream of the event will be embedded below at 1 p.m. S TAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live. Read the rest…

98

98

Drug Topics

OCTOBER 2, 2024

In posters presented at the Heart Failure Society of America 2024 Annual Meeting, researchers assessed how substance use disorders impact cardiovascular outcomes.

112

112

Fierce Pharma

AUGUST 13, 2024

When the FDA approved Amgen’s Imdelltra in May, the T-cell engager was hailed as a breakthrough for the treatment of small cell lung cancer (SCLC) and as the first DLL3-targeting therapy of potenti | In granting an accelerated approval to Amgen's first-in-class DLL3 bispecific Imdelltra, the FDA had to work through a “large number” of missing (..)

FDA 126

FDA 126

pharmaphorum

JANUARY 8, 2023

Before the main event at JP Morgan 2023 even kicks off, we’re checking out the Sachs Associates Neuroscience Innovation Forum on Sunday. The post JP Morgan 2023 – Pre event appeared first on. We’ll also wander over to the UC Davis Health Future & Health CEO Summit a little later this afternoon.

122

122

STAT

DECEMBER 18, 2023

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Since the development of Gleevec two decades ago, precision cancer medicines have become a driving force in biotech and a source of hope for cancer patients. Read the rest…

110

110

STAT

APRIL 25, 2024

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Each year, STAT chooses a new class of Wunderkinds, showcasing stars of science and medicine who are in the midst of launching their careers.

103

103

Drug Topics

OCTOBER 1, 2024

Researchers compared the cardiovascular outcomes of patients hospitalized for heart failure that did or did not experience diabetic emergencies.

Hospitals 200

Hospitals 200

STAT

JANUARY 12, 2024

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.

109

109

pharmaphorum

OCTOBER 8, 2024

Collaboration is essential for the future of healthcare, and events play a pivotal role in fostering it. Learn how collaboration can drive innovation in healthcare through impactful events.

52

52

Drug Topics

JULY 22, 2024

The most common adverse events in patients using oral corticosteroids for more than 90 days included fracture, hyperlipidemia, myocardial infarction, and avascular necrosis.

112

112

pharmaphorum

NOVEMBER 25, 2021

Healthcare professional (HCP) engagement experienced significant shifts during the acute phase of the pandemic, as COVID-19 forced a rethink of traditional pharmaceutical sales and marketing practices, including the digitisation of events. The changing events model. Before COVID, pharma events were mainly face-to-face.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies 98

STAT

MARCH 14, 2024

Editor’s note: A livestream of this event will be embedded below at 1 p.m. Several biosimilar versions of Humira, which for years has been the world’s best-selling medicine, entered the U.S. market over the past year. What has that meant for insurance coverage and the way drugmakers are marketing these medicines?

Insurance Coverage 102

Insurance Coverage Insurance 102

pharmaphorum

SEPTEMBER 4, 2024

Join the PM Society's sixth Careers Event on 26th February 2025, and explore exciting opportunities in the pharmaceutical marketing industry. Connect with industry professionals and kickstart your career.

52

52

Pharmacy Times

MAY 7, 2024

Riello, PharmD, BCPS, discusses the adverse events associated with hepatic encephalopathy (HE) treatments and the importance of encouraging patients to continue first-line medications despite adverse reactions to prevent HE recurrence.

Adverse Reactions 65

Adverse Reactions 65

Drug Store News

SEPTEMBER 19, 2023

In the “Making the Most of Your Vaccines” virtual event, experts will discuss the role pharmacists, nutrition, exercise and mindfulness can play in one’s vaccination experience.

Vaccines 126

Vaccines 126

Hospital Pharmacy Europe

APRIL 12, 2023

Hear the latest developments and innovations in cardiovascular care at a new free event being held in May 2023 In support of our mission to provide high-quality clinical education, Hospital Healthcare Europe , together with Hospital Pharmacy Europe, is proud to announce a new series of events in 2023: the HHE Clinical Excellence programme.

Hospitals 95

Hospitals 95

Pharmacy Times

SEPTEMBER 18, 2024

In 2 studies, durvalumab improved overall survival for those with unresectable hepatocellular carcinoma and event-free survival for muscle-invasive bladder cancer.

65

65

pharmaphorum

FEBRUARY 1, 2024

Explore the current state of pharmaceutical meetings and events in 2024, including the shift from in-person to virtual and hybrid formats. Discover how the industry is embracing diversity, equity, and inclusion in these gatherings.

116

116

Blog: Ask a Student Pharmacist

AUGUST 8, 2024

Events & Continuing Ed pbhamidi Thu, 08/08/2024 - 14:11

52

52

STAT

APRIL 27, 2023

Editor’s Note: A livestream of the event will be embedded below at 1 p.m. Each year, STAT chooses a new class of Wunderkinds, showcasing stars of science and medicine who are in the midst of launching their careers. Read the rest…

98

98

Drug Store News

JANUARY 1, 2024

Don't miss DSN's upcoming events for 2024. Our event programs offer the latest industry content, top-tier speakers, networking opportunities, and more.

52

52

Drug Topics

NOVEMBER 24, 2023

Study authors recommend that healthcare personnel consider prioritizing influenza vaccination for patients with recent cardiovascular diseases (CVDs) in light of new evidence.

Vaccines 232

Vaccines 232

STAT

SEPTEMBER 20, 2023

Editor’s note: A livestream of the event will be embedded below at 1 p.m. Enough talk about fairness, safety, and effectiveness. If we want AI systems to possess these attributes in health care, we have to test them with those goals in mind. Read the rest…

105

105

STAT

MAY 7, 2024

Editor’s note: A livestream of the event will be embedded below at 1 p.m. It took decades for scientists to come up with treatments that could slow the progression of Alzheimer’s disease. Now patients and physicians face a new challenge: actually getting the medicines to people who might benefit from them.

95

95

STAT

JANUARY 13, 2023

Editor’s note: A live stream of the event will be embedded below at 1 p.m. Relive the return to an in-person J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for next week. Read the rest…

98

98

Pharmacy Times

MAY 21, 2024

A medical expert compares CDK4/6 inhibitors and discusses the importance of monitoring specific parameters, such as ECGs and laboratory tests, to minimize adverse events associated with each drug.

65

65

pharmaphorum

MARCH 13, 2024

Discover the most exciting and informative pharma events happening around the world during March, April and 2024. Stay up-to-date with the industry, network with professionals, and gain insights at these global events.

52

52

STAT

JUNE 20, 2024

The outcome of the HELIOS-B study — expected at the end of June or early July — is an enormous stock-moving event for Alnylam Pharmaceuticals. STAT+ subscribers can sign up  here  to get it delivered every Thursday to their inbox.

114

114

Pharmacy Times

MARCH 12, 2024

The findings also indicated that individuals who experienced significant adverse events in childhood were approximately 17% more likely to experience adverse events in adulthood.

65

65

Pharmacy Times

JUNE 30, 2023

Until now, studies examining the relationship between testosterone and adverse cardiovascular events in men with hypogonadism were limited and inconsistent.

123

123